Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 10 (2), 112-117

Helicobacter Pylori Infection: Old and New


Helicobacter Pylori Infection: Old and New

S Diaconu et al. J Med Life.


Helicobacter pylori is a spiral-shaped bacterium that grows in the digestive tract and may be present in more than half of the world's population. The clinical features of Helicobacter pylori range from asymptomatic gastritis to gastrointestinal malignancy. Mucosa-associated lymphoid tissue (MALT) lymphoma is a low-grade B-cell marginal zone lymphoma and Helicobacter pylori has been detected in more than 75% of the patients with MALT lymphoma. Many tests for the detection of Helicobacter pylori are available, including antibody tests, urea breath tests, stool antigen tests and endoscopic biopsies. The eradication of Helicobacter pylori usually prevents the return of ulcers and ulcer complications even after appropriate medications such as PPIs are stopped. The eradication of Helicobacter pylori is important in the treatment of the rare condition of the stomach known as MALT lymphoma. The treatment of Helicobacter pylori to prevent stomach cancer is controversial. Confirmation of eradication is recommended in associated ulcers, persistent dyspepsia despite a test-and-treat approach, MALT lymphoma, and previous treatment for early-stage gastric cancer. The urea breath test and stool antigen test can be used to confirm the eradication and should be performed at least 4 weeks after the completion of therapy. Several diseases have been reported to be associated with Helicobacter pylori infection, including hematologic diseases, such as ITP, idiopathic iron deficiency anemia and vitamin B12 deficiency. There is a positive trend in the association between Helicobacter pylori infection and neurodegenerative disorders and new data showed a reduced risk of death due to stroke and lung cancer but an increased risk of preeclampsia in infected women, which requires further investigations.

Keywords: Helicobacter pylori; gastric carcinoma; gastritis; proton pump inhibitor; ulcer.


Fig. 1
Fig. 1
Natural history of infection with Helicobacter pylori
Fig. 2
Fig. 2
Algorithm for first-line treatment [,]
Fig. 3
Fig. 3
Algorithm for second-line treatment []

Similar articles

See all similar articles

Cited by 13 articles

See all "Cited by" articles


    1. Goh K-L, Chan W-K, Shiota S, Yamaoka Y. Epidemiology of Helicobacter pylori Infection and Public Health Implications. Helicobacter. 2011;16(0-1):1–9. - PMC - PubMed
    1. Ieni A, Barresi V, Rigoli L, Fedele F, Tuccari G, Caruso RA. Morphological and Cellular Features of Innate Immune Reaction in Helicobacter pylori Gastritis: A Brief Review. International Journal of Molecular Sciences. 2016;17(1):109. - PMC - PubMed
    1. American College of Physicians (2003- ) MKSAP 17: medical knowledge self-assessment program. Philadelphia, Pa.: American College of Physicians; 2015.
    1. Watari J, Chen N, Amenta PS, et al. Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development. World Journal of Gastroenterology: WJG. 2014;20(18):5461–5473. - PMC - PubMed
    1. Liou J-M, et al. Association of H. pylori and Gastric Cancer in Observational Studies. In: Suzuki H, ed. Helicobacter pylori. New York, NY: Springer Berlin Heidelberg; 2016. pp. 183–188.

MeSH terms

LinkOut - more resources